#VisualAbstract: Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
1. Luspatercept may significantly reduce transfusion burden in patients with lower-risk myelodysplastic syndromes with ring sideroblasts for whom erythropoiesis-stimulating agents ...